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Abstract
Background. Altered expression of the complement component C4A gene is a known risk
factor for schizophrenia. Further, predicted brain C4A expression has also been associated
with memory function highlighting that altered C4A expression in the brain may be relevant
for cognitive and behavioral traits.
Methods. We obtained genetic information and performance measures on seven cognitive
tasks for up to 329 773 individuals from the UK Biobank, as well as brain imaging data for
a subset of 33 003 participants. Direct genotypes for variants (n = 3213) within the major
histocompatibility complex region were used to impute C4 structural variation, from which
predicted expression of the C4A and C4B genes in human brain tissue were predicted.
We investigated if predicted brain C4A or C4B expression were associated with cognitive per-
formance and brain imaging measures using linear regression analyses.
Results.We identified significant negative associations between predicted C4A expression and
performance on select cognitive tests, and significant associations with MRI-based cortical
thickness and surface area in select regions. Finally, we observed significant inconsistent par-
tial mediation of the effects of predicted C4A expression on cognitive performance, by specific
brain structure measures.
Conclusions. These results demonstrate that the C4 risk locus is associated with the central
endophenotypes of cognitive performance and brain morphology, even when considered
independently of other genetic risk factors and in individuals without mental or neurological
disorders.
Introduction
The major histocompatibility complex (MHC) is located on chromosome 6 and is implicated in
a number of autoimmune diseases (Howson, Walker, Clayton, & Todd, 2009; Kamitaki et al.,
2020; Raychaudhuri et al., 2012). In addition, genetic variants within this region are consistently
associated with risk of schizophrenia (International Schizophrenia Consortium et al., 2009;
Pardiñas et al., 2018; Schizophrenia Psychiatric Genome-Wide Association Study (GWAS)
Consortium, 2011; Schizophrenia Working Group of the Psychiatric Genomics Consortium,
2014; Shi et al., 2009; Stefansson et al., 2009). These associations corroborate serological studies
which identified altered levels of inflammatory markers in schizophrenia patients, including
complement proteins (Hakobyan, Boyajyan, & Sim, 2005; Laskaris et al., 2019; Maes et al.,
1997; Mayilyan, Arnold, Presanis, Soghoyan, & Sim, 2006; Mayilyan, Dodds, Boyajyan,
Soghoyan, & Sim, 2008a; Mayilyan, Weinberger, & Sim, 2008b). These findings suggest the
involvement of an immune component in psychiatric disorders such as schizophrenia.
In order to better understand the mechanisms underlying the MHC genetic association
with schizophrenia, a fine-mapping molecular investigation of the region was conducted
and identified that variants within the complement component 4 (C4) gene locus are respon-
sible for at least part of the association signal (Sekar et al., 2016). The C4 protein is one of a
number of proteins that make up the complement system (Charles, Janeway, Travers, Walport,
& Shlomchik, 2001), part of the innate immune system. Complement components were ini-
tially shown to modulate neurogenesis in murine primary cortical cell cultures (van Beek
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et al., 2001). Further investigation of the role of complement com-
ponents in the central nervous system of genetically modified
mice identified its major role in modulating synaptic plasticity
(Hong et al., 2016; Stephan, Barres, & Stevens, 2012; Stokowska
et al., 2017; Vasek et al., 2016). More recently, complement com-
ponents were implicated in neuronal migration (Gorelik et al.,
2017) and apoptosis (Niculescu et al., 2004) in the central nervous
system. Additional evidence for the activity of the complement
system in the brain, and its involvement in the pathogenesis of
schizophrenia is summarized in recent reviews (Druart & Le
Magueresse, 2019; Nimgaonkar, Prasad, Chowdari, Severance, &
Yolken, 2017; Tenner, Stevens, & Woodruff, 2018; Woo, Pouget,
Zai, & Kennedy, 2019).
The C4 gene is present as one of two isotypes (C4A and C4B)
and the structural variation between these isotypes, as well as their
copy number, was shown to significantly alter the expression level
of C4 in post-mortem brain tissue (Sekar et al., 2016). A model of
this relationship can be used to predict C4A gene expression in
the brain based on an individual’s genotype. Using this procedure,
predicted C4A gene expression was associated with risk of schizo-
phrenia in an independent sample (Sekar et al., 2016). Finally, C4
proteins localized to the synapses in post-mortem human brains,
and C4 was also demonstrated to modulate synaptic pruning in
mice (Sekar et al., 2016), and human-derived neural cultures
(Sellgren et al., 2017, 2019).
Independent of these findings, variants within the MHC region
were also associated with cognitive performance (Athanasiu et al.,
2017; Donohoe et al., 2013; Zhang, Lv, Fan, Tang, & Yi, 2017)
and brain structure (Walters et al., 2013) in patients with schizo-
phrenia. Based on these studies, Donohoe et al. (2018) showed
that increased predicted C4A expression was associated with poorer
performance in memory recall measures in a cohort of psychosis
patients and healthy controls, as well as in patients only. The dir-
ection of effect in control participants was similar to that observed
in patients, however, the effect size was smaller and non-significant.
In addition, they demonstrated that higher predicted C4A expres-
sion was associated with lower cortical activity in the middle tem-
poral cortex during visual processing in healthy participants
(Donohoe et al., 2018). In support of these findings, complement-
dependent synapse elimination was recently identified as a mech-
anism for memory loss (Wang et al., 2020). These results highlight
that C4A expression in the brain may be associated with cognitive
and behavioral traits not only in patients with psychiatric disorders
but also in healthy individuals.
Based on this, our primary aim was to investigate if predicted
brain C4A expression is associated with cognitive performance in
a large adult population-based sample (UK Biobank), without
mental or neurological disorders. We hypothesized that higher
predicted C4A expression would be associated with lower cogni-
tive performance, however, we did not start with any a priori
assumptions regarding the specific cognitive tasks investigated.
Our secondary aims were to investigate if predicted brain C4A
expression is associated with differences in brain structure and
if observed effects on cognitive performance may be mediated
by C4A-associated differences in brain structure.
Methods
The UK Biobank cohort
The UK Biobank cohort and available data are described else-
where (Bycroft et al., 2018). Briefly, the UK Biobank project is a
prospective cohort study with genetic and phenotypic data col-
lected on approximately 500 000 individuals from across the
UK. Multimodal imaging assessments are underway, with mag-
netic resonance imaging (MRI) of the brain currently available
for a subset of individuals (Miller et al., 2016). All data used in
this study were obtained from the UK Biobank (http://www.
ukbiobank.ac.uk) through application 27412.
We limited the cohort to 409 629 Caucasian individuals
(Datafield-22006). This subset is defined as those individuals
who self-identified as ‘White British’ and that had similar genetic
ancestry based on a principal component analysis (online
Supplementary Fig. S1). Individuals with a diagnosed mental or
neurological disorder were excluded (Datafields-41202,41204;
F/G codes). One from each pair of individuals with a kinship
coefficient above 0.053 was also removed prior to analyses
(Datafield-2201122012).
The final cohort sample size, after exclusions, with available
genetic data was 329 773 (median age 59, range: 40–74). The sam-
ple included 152 966 men (median age 59, range: 40–74) and 176
807 women (median age 58, range: 40–71).
All participants provided informed consent prior to enrol-
ment. The authors assert that all procedures contributing to this
work comply with the ethical standards of the relevant national
and institutional committees on human experimentation and
with the Helsinki Declaration of 1975, as revised in 2008.
Genotyping and quality control
Genotyping of the UK Biobank cohort was performed on two
similar arrays. Approximately 50 000 samples were genotyped
on the UK BiLEVE array and the remaining 450 000 samples
were genotyped on the UK Biobank Axiom array. Further details
regarding genotyping and quality control procedures for the UK
Biobank are well documented (Bycroft et al., 2018).
Imputation of C4 structural variation and genetically predicted
C4a expression
Direct genotypes for variants (n = 3213) within the MHC region
were used to impute C4 structural variation. This analysis was
performed using the 222 haplotype-integrated variant and C4 ref-
erence panel (Sekar et al., 2016). The distribution of C4 structural
variants was similar to previously described (online
Supplementary Table S1) (Sekar et al., 2016; Kamitaki et al.,
2020). The imputed C4 structural alleles were then used to deter-
mine C4 isotype (C4A, C4B, C4L, and C4S) copy numbers. Here
C4A and C4B refer to the two isotypes of the C4 gene, while C4L
and C4S refer to ‘long’ and ‘short’ forms of the gene due to the
presence or absence of a human endogenous retroviral (HERV)
insertion, respectively. We calculated values for the predicted
expression of the C4A gene in human brain tissue, based on the
previously identified relationship between C4 isotype copy num-
ber and C4A gene expression (Sekar et al., 2016). The predicted
C4A expression values ranged between 0 and 2.35 (mean = 1.08,
standard deviation = 0.36) (online Supplementary Fig. S2).
A summary of this methodology is presented in Fig. 1.
Predicted C4B expression values were calculated following a simi-
lar approach. Predicted C4A and C4B expression values were used
for association with cognitive tasks and brain imaging measures
since these variables allow for use of standard linear regression
analyses instead of ordinal regression using structural variants.
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Cognitive tasks
We obtained performance measures on seven cognitive tasks from
the UK Biobank, and processed them as previously described
(Kendall et al., 2017, 2019). Briefly, measures for analysis included
the Pairs Matching task (episodic memory, Datafield-399, out-
come: total number of errors), the Reaction Time task (simple
processing speed, Datafield-20023, outcome: mean reaction time
to correct responses), the Fluid Intelligence test (reasoning and
problem solving, Datafield-20016, total number of correct
answers), the Digit Span task (numeric working memory,
Datafield-4282, outcome: maximum number of digits remem-
bered), the Symbol Digit Substitution task (complex processing
speed, Datafield-20195, outcome: number of correct substitu-
tions), and the Trail Making A and B tasks (visual attention,
Datafields-20156,20157, outcome: time taken to complete these
tests). All data were recoded so that higher scores indicate better
performance. The number of participants that completed each of
these performance measures, with available predicted C4A and
C4B expression values and brain imaging data, is provided in
Table 1.
Image acquisition and processing
Imaging assessments were conducted at three centers, using the
same hardware, software and protocols. A detailed description
of the processes for data acquisition, processing and quality con-
trol is available (Alfaro-Almagro et al., 2018). The data release
from UK Biobank used in this study included 33 003 participants.
C4A and C4B expression values were predicted for 27 087 of these
participants.
We processed T1-weighted MRI scans from all individuals
using the standardized recon-all pipeline of FreeSurfer (Fischl
et al., 2002; Fischl, 2012). Furthermore, for each scanner site,
we regressed age and sex from the Euler number of both left
and right hemispheres and individuals whose Euler numbers
were less than 3 standard deviations below the residualized
Euler numbers were excluded as outliers (n = 618) (Kaufmann
et al., 2019). Analyzed brain imaging measures included surface
area and mean thickness of 34 cortical regions, total cortical sur-
face area, and mean cortical thickness, the volumes of seven sub-
cortical regions, and total intracranial volume (ICV). The total
surface area, thickness or volume of each region was calculated
by summing the right and left hemispheres.
Statistical analyses
To determine the relationship between cognitive performance and
predicted C4A and C4B expression, we performed linear
Fig. 1. A schematic diagram of the methodology used to obtain predicted expression values for the C4A gene within brain tissue, as described by Sekar et al. (2016).
First, (a) individual genotypes are determined and SNP haplotypes are then inferred from this data. (b) The SNP haplotypes can be grouped into haplogroups and
each haplogroup corresponds to a specific C4 locus structure. Four of these structures are common (represented here) and 11 are less common (<10% frequency
combined). HERV, human endogenous retroviral insertion. (c) Structures with higher copy numbers of C4A and C4L (both C4AL and C4BL) isotypes show higher C4A
expression in brain tissue. (d ) C4A gene expression can be predicted based on the data outlined in panels A–C. AL, AS, BL, and BS refer to the copy number of each
of these isotypes in the C4 locus structure. Structures containing the AS combination are omitted from panels A to C since they are rare, with a frequency of
approximately 1% (online Supplementary Table S1) (Sekar et al., 2016). This figure is a schematic and was not generated from actual genotype, expression or
other data.
Table 1. Numbers of participants that completed each of the seven cognitive






With C4A and C4B
expression Values and
Brain Imaging Data (n)
Pairs matching 329 465 21 989




Digit span 34 171 2195
Symbol Digit
Substitution
81 444 11 696
Trail Making A 71 933 10 427
Trail Making B 71 931 10 427
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regression analyses with each cognitive task as the outcome vari-
able, predicted C4A or C4B expression as the predictor variable
and common covariates, which included age, age-squared, sex,
genotyping batch, the first 10 genetic principal components and
educational attainment. A summary of the effects of these covari-
ates on C4A and C4B expression is provided in online
Supplementary Table S2. Age-squared was included since this
allows the model to accommodate a non-linear relationship
between age and the outcome variable if one exists. Educational
attainment was determined by the highest qualification obtained
by each individual at the time of assessment (Datafield-6138).
No significant associations were identified between predicted
C4B expression and cognitive tasks (online Supplementary
Table S3), and therefore predicted C4B expression was not tested
for associations with brain imaging measures.
To investigate the relationship between brain imaging mea-
sures and predicted C4A expression values, brain imaging mea-
sures were first normalized in R 3.5.0 by an inverse normal
transformation of the residual of linear regression on the pheno-
type correcting for covariates, as previously described (Sønderby
et al., 2018). This transformation results in normally distributed
covariate-corrected values that were used for downstream analysis.
Covariates included the common covariates mentioned above as
well as Euler number (Rosen et al., 2018). Regional measures of
surface area and mean thickness were corrected for total cortical
surface area and total mean cortical thickness, respectively.
Subcortical volumes were corrected for ICV.
To determine the association between of predicted C4A
expression and brain structure, we performed linear regression
analyses with the covariate-corrected brain imaging measure as
the outcome and predicted C4A expression as the predictor vari-
able in the model.
Finally, to determine if the effects of predicted C4A expression
on cognitive tasks were mediated by brain imaging measures, add-
itional linear regression analyses were performed with each cogni-
tive task as the outcome variable, predicted C4A expression, a
regional non-covariate-corrected brain imaging measure and cov-
ariates. Covariates included the common covariates, Euler num-
ber (Rosen et al., 2018), and educational attainment. Regional
measures were corrected for using global measures as described
above. Mediation analysis was then performed using the R pack-
age mediation v4.4.6, using the bootstrapping method and 5000
simulations per test (Writing Committee for the
ENIGMA-CNV Working Group et al., 2019). All significant
results are also shown in the context of a mediation model
(Fig. 2). A previous study investigating the effects of brain
imaging measures on cognitive performance in the UK Biobank
has shown significant positive correlations between all of the
brain imaging measures included in this study and increased cog-
nitive performance (Cox, Ritchie, Fawns-Ritchie, Tucker-Drob, &
Deary, 2019). Those results correspond to path b in the mediation
analyses performed in this study (Fig. 2).
Since sex-specific C4A risk effects were recently identified
(Kamitaki et al., 2020), additional analysis was performed as
above with the inclusion of an interaction term between C4A
expression and sex (online Supplementary Table S4). The number
of male and female participants that completed each of the per-
formance measures, with available predicted C4A and C4B expres-
sion values and brain imaging data, is provided in online
Supplementary Table S5.
The distributions of residuals from all models were examined
and determined to be normal indicating that linearity
assumptions were not violated. Effect sizes reported are the stan-
dardized estimates of beta (β) from the linear regressions. The
partial correlation coefficient (r) was computed from the
t-statistics for the main cognitive and brain structure analyses
(online Supplementary Tables S6–S9). The distribution of values
for significantly associated cognitive performance tests and brain
imaging measures were plotted against ‘binned’ predictions of
C4A expression levels (online Supplementary Figs S3–S5) and
analysis of variance tests and post-hoc Tukey tests were used to
determine the differences between these ‘bins’ (online
Supplementary Tables S10–S12). Empirical p values were
converted to False Discovery Rate (FDR) q-values using the R
package qvalue v2.14.1. FDR was computed independently for
the analyses of cognitive tests (n = 7), brain morphology
(n = 79) and mediation (n = 33). Results were considered signifi-
cant if FDR <0.05. Plots were generated using R library ggplot2
v2.2.1 (Wickham, 2009, p. 2) and the R package ggseg v1.5.1.
Results
Effect of C4a expression on cognitive performance
Predicted C4A expression was significantly (FDR < 0.05) asso-
ciated with three of the seven cognitive tests (Fig. 2i, Table 2,
online Supplementary Table S6). Specifically, higher predicted
C4A expression was associated with reduced cognitive perform-
ance in the pairs matching (Std. β =−0.006, t-value = −3.28,
FDR = 0.009), fluid intelligence (Std. β =−0.008, t-value = −2.86,
FDR = 0.032), and symbol digit substitution (Std. β =−0.008,
t-value =−2.75, FDR = 0.043) cognitive tasks. Analysis of the
association between predicted C4A expression and cognitive per-
formance measures indicates a linear relationship, not a distinct
range of expression above or below which the observed changes
occur (online Supplementary Table S10). No significant C4A–
sex interactions were identified for any of the cognitive tests
(online Supplementary Table S4).
Effect of C4a expression on brain imaging measures
Predicted C4A expression was significantly (FDR < 0.05) asso-
ciated with three cortical surface area measures (Fig. 3a, online
Supplementary Table S7). Specifically, higher C4A expression
was associated with reduced surface area for the transverse tem-
poral measure (Std. β =−0.016, t-value =−2.68, FDR = 0.045),
and increased surface area of the insula (Std. β = 0.029, t-value
= 4.70, FDR = 1.735 × 10−4), and middle temporal (Std.
β = 0.025, t-value = 4.15, FDR = 7.458 × 10−4) measures, respect-
ively (Fig. 2ii).
When considering mean cortical thickness, predicted C4A
expression was significantly associated with eight measures, the
majority (6 of 8) of which were negatively associated with C4A
expression (Fig. 3b, online Supplementary Table S8).
Specifically, the parahippocampal (Std. β =−0.026, t-value =
−4.22, FDR = 7.458 × 10−4), insula (Std. β =−0.024, t-value =
−3.96, FDR = 1.277 × 10−3), isthmuscingulate (Std. β =−0.021,
t-value =−3.38, FDR = 9.865 × 10−3), entorhinal (Std. β =
−0.020, t-value = −3.22, FDR = 0.014), medial orbitofrontal (Std.
β = −0.019, t-value = −3.14, FDR = 0.016) and posterior cingulate
(Std. β =−0.019, t-value =−3.08, FDR = 0.017) measures
(Fig. 2ii).
No significant associations were identified between predicted
C4A expression and subcortical volumes. In addition, no other
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Fig. 2. A summary of the results from the significant (FDR <0.05) linear regression models of predicted C4A expression values on cognitive performance and brain
imaging measures. The results are presented in the context of a mediation model. (i) Higher predicted C4A expression was significantly associated with the results
from three cognitive tasks. Path c = Cognitive task ∼ C4A expression (ii) Predicted C4A expression was significantly associated with some measures of cortical surface
area and cortical thickness. Path a = Brain imaging measure∼ C4A expression. (iii) A summary of the brain imaging measures identified to significantly mediate the
effect of predicted C4A expression on cognitive performance. Path ab = Cognitive task ∼ C4A expression mediated by brain imaging measures. The proportion of the
total effect (Panel i, Path c) mediated by changes in the corresponding brain imaging measure is shown (Prop. Med = ab/c). Negative proportion values indicate
inconsistent mediation. Inconsistent mediation occurs when the direction of effect of the direct effect (c’) and the indirect effect (ab) is in the opposite direction.
The standardized β (Std. β) is shown to indicate the size and direction of effect of higher C4A expression on each outcome measure. The green and red headers
indicate an increase or decrease in each outcome measure, respectively.
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regional brain measures, or global measures including total
cortical surface area, total mean cortical thickness and ICV,
were significantly associated with predicted C4A expression
(online Supplementary Tables S7–S9). As with cognitive perform-
ance, further analysis of the association between predicted C4A
expression and regional brain imaging measures indicates
that this relationship is linear and that there is not a distinct
range of expression above or below which the observed changes
occur (online Supplementary Tables S11–S12 and online
Supplementary Figs S3–S5). Hemisphere-specific results are pro-
vided in the supplement (online Supplementary Tables S13–S15).
A summary of the effects of predicted C4A expression on brain
imaging measures, and how these results are incorporated into
the mediation analyses are shown in Fig. 2ii.
No significant C4A–sex interactions were identified for any
brain imaging measures (online Supplementary Tables S16–S18).
Table 2. A summary of the results from the significant linear regression models of predicted C4A expression values on cognitive performance
Phenotype and Covariates R Std. β Std. Error Uncorrected p value FDR
Pairs matching
C4A expression −0.006 −0.006 0.003 1.046 × 10−3 9.212 × 10−3
Age −0.128 −0.135 0.675 <1 × 10−300 <1 × 10−300
Sex (Male) 0.016 0.016 0.002 4.204 × 10−20 5.028 × 10−19
Fluid Intelligence
C4A expression −0.009 −0.008 0.016 4.174 × 10−3 0.032
Age −0.011 −0.011 0.001 2.415 × 10−4 2.319 × 10−3
Sex (Male) 0.066 0.059 0.012 1.209 × 10−101 2.838 × 10−100
Symbol Digit Substitution
C4A expression −0.010 −0.008 0.040 5.930 × 10−3 0.043
Age −0.451 −0.455 0.002 <1 × 10−300 <1 × 10−300
Sex (Male) −0.007 −0.006 0.029 5.477 × 10−2 0.248
All models also included age squared, educational attainment, genotyping batch, and the first 10 genetic principal components as covariates (data not shown). r = Partial correlation
coefficient. Std. β = Standardized β. Std. Error = Standard Error.
Fig. 3. The effect of C4A expression on regional measures of (a) cortical surface area and (b) mean cortical thickness. The colors correspond to the standardized β
(Std. β) coefficient for each brain region from the linear regressions. Black demarcations around a brain region indicate that it passes the multiple comparisons–
corrected significance threshold of FDR <0.05. a, Insula. b, Transverse temporal. c, Middle temporal. d, Cuneus. e, Pericalcarine. f, Posterior cingulate. g,
Isthmuscingulate. h, Parahippocampal. i, Entorhinal. j, Medial orbitofrontal.
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Indirect effect of C4a expression on cognitive performance –
mediation by brain imaging measures
Mediation analyses highlighted that increases in insula surface
area and medial orbitofrontal thickness are linked to significant
(FDR < 0.05) inconsistent mediation of the effect of higher pre-
dicted C4A expression on two measures of cognitive performance
(Fig. 2iii), i.e. the changes in brain imaging measures partially
suppress the negative effects of higher C4A expression on cogni-
tive performance. None of the included brain imaging measures
was identified as significant mediators of the effect of predicted
C4A expression on fluid intelligence scores (online
Supplementary Table S19).
Discussion
Here we identified novel significant associations between pre-
dicted brain C4A expression and cognitive performance in a
large adult volunteer sample of individuals without mental or
neurological disorders. Additionally, we showed that predicted
C4A expression was significantly associated with regional cortical
thickness and surface area. Further analysis of these associations
revealed that their relationships are linear, and that there is no
distinct threshold value for predicted C4A expression, highlight-
ing that multiple factors likely influence cognition and brain
morphology in these individuals within the normal range.
Finally, we identified significant inconsistent partial mediation
of the effects of C4A expression on cognitive performance, by spe-
cific brain imaging measures. This indicates that the differences
observed in brain morphology may help to protect against
C4A-associated cognitive deficits. In addition, our observations
of lower cognitive performance and differences in brain imaging
measures are highly unlikely to be secondary to any mental or
neurological disorders or the treatment thereof since we excluded
individuals with diagnosed mental or neurological disorders, and
the remaining individuals within the UK Biobank tend to be
healthier than the general population (Fry et al., 2017).
The main finding of this study is the negative association
between predicted C4A expression in the brain and episodic
memory (Pairs Matching task), reasoning and problem solving
(Fluid Intelligence test) and complex processing speed (Symbol
Digit Substitution task). Our regression modelling shows that
the effects of predicted C4A expression, in some instances, are
comparable in size to known modifiers of cognitive performance,
such as with age for fluid intelligence and with sex for symbol
digit substitution (Table 2). As expected, when comparing these
effect sizes to those of rare copy number variants (CNVs) with
known cognitive effects, a study on the same UK Biobank parti-
cipants showed that most such CNVs had a greater effect on cog-
nitive performance than that observed for predicted C4A
expression in this study (Kendall et al., 2019). These results are
in line with previous findings, that higher predicted C4A expres-
sion is associated with poorer performance in memory recall mea-
sures in psychosis patients (Donohoe et al., 2018) and that the
complement system modulates memory loss (Wang et al.,
2020), and further demonstrate that these effects are present
within unaffected individuals. Predicted C4B expression was not
associated with cognitive performance, the effect of the C4
locus was limited to C4A as suggested by previous findings
(Donohoe et al., 2018; Sekar et al., 2016). Moreover, we did not
identify any strong correlation between schizophrenia polygenic
risk score and predicted C4A expression (data not shown),
implying that predicted C4A expression is not a proxy for schizo-
phrenia polygenic risk in the UK Biobank sample analyzed.
Cognitive impairments reliably distinguish between schizo-
phrenia patients and healthy controls, with large effect sizes in
meta-analyses (Mesholam-Gately, Giuliano, Goff, Faraone, &
Seidman, 2009). Moreover, similar observations, with smaller
effects, for measures of processing speed, attention and memory
have also been identified when comparing first-degree relatives
of schizophrenia patients to healthy controls (Hou et al., 2016).
At a molecular level, shared common variants contributing to
both schizophrenia risk and cognitive performance have also
been identified (Smeland et al., 2019). These studies highlight
cognitive impairment as a core heritable feature of schizophrenia
(Barch & Ceaser, 2012; Bora, Yücel, & Pantelis, 2010), which may
manifest in both affected patients and healthy individuals with
some genetic burden for the disorder. Cognitive deficits have
been associated with poorer functional outcomes regardless of
age, sex or chronicity of the disorder (Fett et al., 2011). This
lead to the suggestion that common mechanisms might modulate
individual differences within these cognitive domains, e.g. related
to the structure, function and/or connectivity of prefrontal, par-
ietal, cingulate and insula brain regions (Barch & Ceaser, 2012).
Our brain imaging results highlight that C4A expression may
potentially act as one of the causative factors in such mechanisms.
We identified significant associations between predicted C4A
expression and cortical surface area and/or mean cortical thick-
ness within temporal, cingulate and insula cortex, amongst others
(Figs 1ii and 2). In line with previous observations of structural
brain abnormalities in patients with schizophrenia (Cobia,
Csernansky, & Wang, 2011; van Haren et al., 2011; Kubota
et al., 2011; Assunção Leme et al., 2013; Moberget et al., 2018;
Alnæs et al., 2019), and more recent associations between schizo-
phrenia polygenic score and structure in unaffected individuals
(Alnæs et al., 2019; Neilson et al., 2019; Westlye, Alnæs, van
der Meer, Kaufmann, & Andreassen, 2019), higher predicted
C4A expression was mostly associated with smaller cortical sur-
face area and lower mean cortical thickness (7/11 brain imaging
measures, Fig. 2ii). These results, together with our findings on
cognitive performance, provide further evidence that some of
the common genetic underpinnings of schizophrenia may have
similar effects in individuals without mental disorders, in line
with dimensional and polygenic risk models (Boyle, Li, &
Pritchard, 2017; Purcell et al., 2009; Timpson, Greenwood,
Soranzo, Lawson, & Richards, 2018).
In contrast to these results, higher predicted C4A expression
was also associated with increased cortical surface area and
mean cortical thickness in a subset of brain regions (4/11 brain
imaging measures, Fig. 2ii). Among these regions with an
increased cortical surface area are the insula and the middle tem-
poral cortices. This is contrary to what is observed in schizophre-
nia patients where the cortical surface area of these regions is
reduced (Assunção Leme et al., 2013; Cobia et al., 2011; Kubota
et al., 2011; van Haren et al., 2011). Interestingly, however, a lar-
ger cortical surface area has previously been identified in
unaffected relatives of schizophrenia patients when compared to
non-relative controls (Goghari, Rehm, Carter, & MacDonald,
2007). That study showed that relatives had increased gray matter
volume and surface area in the left hemisphere, bilaterally in the
parahippocampal gyri, and in the left middle temporal lobe,
thereby implicating the cingulate and temporal regions which
are known to be associated with higher level cognitive, affective,
and memory functions (Goghari et al., 2007). The authors
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suggested two possible explanations for these observed increases
in the gray matter of relatives; (i) abnormal cell migration and
deficient pruning, and (ii) a protective or compensatory factor
against the development of psychosis or loss of associated func-
tioning (Córdova-Palomera et al., 2018; Goghari et al., 2007).
Given the molecular functions of complement C4 in the brain,
our results could support their suggestion of altered cell migration
and synaptic pruning. Moreover, our mediation analyses also sug-
gest the presence of compensatory factors against C4A-associated
cognitive deficits in individuals without mental disorders.
Previous large scale studies investigating the differences in
brain imaging measures between schizophrenia patients and
healthy controls show prolific effects of the disorder on numerous
measures of cortical surface area and thickness (van Erp et al.,
2018), as well as subcortical volumes (van Erp et al., 2016).
Although these effects are considered small to medium, they are
much larger than the effects of C4A expression observed in the
present study. Thus, although the changes in brain structure in
schizophrenia may be influenced by the level of C4A expression,
a large number of genetic and environmental factors likely con-
tribute, as suggested by previous studies (Lee et al., 2016).
Brain imaging measures were previously shown to correlate
positively with general cognitive performance in the UK
Biobank (Cox et al., 2019). Since we had identified a significant
negative effect of C4A expression on cognitive task performance
and significant effects on brain imaging measures (predominantly
in the negative direction) (Fig. 2), we expected ex ante to observe
consistent mediation via the indirect effect (Fig. 2iii, path ab), i.e.
that some proportion of the effect of C4A expression on cognitive
performance would be accounted for by the effect of C4A expres-
sion on brain imaging measures. All of our observations, however,
were of inconsistent mediation, i.e. that changes in brain struc-
ture, directly or indirectly related to higher C4A expression,
may act in a protective or compensatory manner against
C4A-associated cognitive deficits. Significant C4A-associated
increases in insula surface area were shown to partially mediate
the effects of C4A expression on cognitive performance
(Fig. 2iii). Specifically, increased insula surface area suppressed
the negative effects of C4A expression on episodic memory
(Pairs Matching task) and complex processing speed (Symbol
Digit Substitution task) by approximately 15% (Fig. 2iii).
Despite the significant correlation identified between C4A expres-
sion and insula surface area, these mediation results suggest that
this relationship is driven by additional components other than
C4A expression. Rather, the increase in insula surface area is
the result of some undetermined mechanism in response to
increased C4A expression. A similar compensatory relationship
was identified between C4A expression, cognitive performance,
and mean medial orbitofrontal cortical thickness (Fig. 2iii).
Increased medial orbitofrontal cortical thickness suppressed the
negative effects of C4A expression on episodic memory (Pairs
Matching task) by approximately 9% (Fig. 2iii). In this instance,
however, predicted C4A expression was negatively associated
with mean medial orbitofrontal cortical thickness. Thus, the
observed relationship between C4A expression and medial orbito-
frontal cortical thickness is likely driven by increased C4A expres-
sion, and the observed protective effect is likely driven by another
distinct mechanism in order to compensate for the effects of
increased C4A expression.
Partial mediation of the effects of C4A expression on cognitive
performance, by changes in brain imaging measures, suggests that
additional mechanisms play a role in modulating this relationship.
Furthermore, given the healthier bias of UK Biobank participants
(Fry et al., 2017), further exaggerated by our removal of indivi-
duals with mental or neurological disorders, it is tempting to
speculate that these participants may share other protective or
compensatory factors, in addition to the brain imaging differences
identified in this study, which might mask the true effect of C4A
expression on cognitive performance. Thus, the true effect would
likely be greater in an unbiased population cohort. Future studies
should identify additional factors associated with changes in C4A
expression and cognitive performance in order to determine other
mechanisms that might contribute to their relationship.
A limitation to the current study is that the UK Biobank has an
older age distribution in comparison to patients included in most
schizophrenia studies, which are commonly conducted on indivi-
duals within an age range more closely matching the age of onset
of the disorder (18–25 years). As a result, despite controlling for
age in our analyses, we cannot exclude a potential effect of aging
on the results. Studies in prospective cohorts are required to
address this limitation. A second limitation is the reduced sample
size for some of the cognitive tasks. Since the identified significant
effects of C4A expression of cognitive tasks were small, and pre-
dominantly identified for those tasks with the largest sample
sizes, these reduced numbers may have resulted in false negatives.
Future studies with larger samples for these cognitive tasks are
required to determine their true relationship with C4A expression.
Finally, the significant effects of C4A expression on cognitive per-
formance and brain morphology identified in this study are very
small. By comparison, the effects of brain imaging measures on
cognitive performance are magnitudes greater than the effects
of C4A expression on cognitive performance (online
Supplementary Table S20). This highlights that a large number
of additional genetic and environmental factors contribute to
these phenotypes.
In conclusion, we observed that higher predicted C4A expres-
sion is associated with lower cognitive performance and regional
cortical surface area and thickness. Moreover, we provide evi-
dence that the observed changes in cognitive performance, as a
result of predicted C4A expression, may be mediated by
C4A-associated changes in brain structure. These results demon-
strate that C4 locus affects cognition and brain morphology in
individuals without mental or neurological disorders.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291721000179.
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